Capricor Therapeutics, Inc. (CAPR)
8.95
+0.01
(+0.11%)
USD |
NASDAQ |
Oct 02, 16:00
9.02
+0.07
(+0.78%)
After-Hours: 20:00
Capricor Therapeutics Market Cap : 520.08M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 520.08M |
| October 01, 2026 | 519.49M |
| September 30, 2026 | 550.29M |
| September 29, 2026 | 497.99M |
| September 28, 2026 | 506.13M |
| September 25, 2026 | 485.79M |
| September 24, 2026 | 497.99M |
| September 23, 2026 | 503.80M |
| September 22, 2026 | 542.74M |
| September 21, 2026 | 517.17M |
| September 18, 2026 | 526.47M |
| September 17, 2026 | 547.39M |
| September 16, 2026 | 497.41M |
| September 15, 2026 | 497.41M |
| September 14, 2026 | 511.94M |
| September 11, 2026 | 486.37M |
| September 10, 2026 | 482.30M |
| September 09, 2026 | 502.06M |
| September 08, 2026 | 526.47M |
| September 04, 2026 | 546.22M |
| September 03, 2026 | 539.25M |
| September 02, 2026 | 574.70M |
| September 01, 2026 | 581.67M |
| August 31, 2026 | 575.86M |
| August 28, 2026 | 557.27M |
| Date | Value |
|---|---|
| August 27, 2026 | 584.58M |
| August 26, 2026 | 543.90M |
| August 25, 2026 | 481.72M |
| August 24, 2026 | 395.14M |
| August 21, 2026 | 365.51M |
| August 20, 2026 | 397.18M |
| August 19, 2026 | 463.71M |
| August 18, 2026 | 411.41M |
| August 17, 2026 | 432.91M |
| August 14, 2026 | 386.42M |
| August 13, 2026 | 244.64M |
| August 12, 2026 | 243.48M |
| August 11, 2026 | 228.37M |
| August 10, 2026 | 223.72M |
| August 07, 2026 | 235.85M |
| August 06, 2026 | 241.04M |
| August 05, 2026 | 226.62M |
| August 04, 2026 | 240.46M |
| August 03, 2026 | 242.19M |
| July 31, 2026 | 222.01M |
| July 30, 2026 | 241.62M |
| July 29, 2026 | 378.86M |
| July 28, 2026 | 378.86M |
| July 27, 2026 | 403.36M |
| July 24, 2026 | 1.136B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ARS Pharmaceuticals, Inc. | 404.71M |
| SELLAS Life Sciences Group, Inc. | 2.371B |
| Sionna Therapeutics, Inc. | 221.76M |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Cytokinetics, Inc. | 9.103B |
Market Cap Related Metrics
| PEG Ratio | -0.0742 |
| Price to Book Value | 2.112 |
| Price | 8.95 |
| Earnings Yield | -27.37% |
| PEGY Ratio | -0.0742 |